脉血康胶囊治疗老年恢复期脑梗死疗效观察

Clinical observations of Maixuekang capsule on old patients with convalescing cerebral infarction

目的观察脉血康胶囊治疗老年恢复期脑梗死的临床疗效及安全性。方法将180例年龄60岁以上的老年恢复期脑梗死患者分为研究组90例、对照组90例,两组都给以口服复方丹参片、尼莫地平片、阿司匹林肠溶片、吡拉西坦片等常规治疗,并控制血糖、血脂,调控血压,研究组在此基础上加服脉血康胶囊4粒,每日3次;两组疗程均为6周。结果研究组总有效率为92.22%,对照组总有效率为77.78%,研究组优于对照组,两组比较差异有统计学意义(P<0.05);研究组血液流变学指标改善明显(P<0.05),而对照组改善不明显(P>0.05);两组均无明显不良反应。结论脉血康胶囊治疗老年恢复期脑梗死疗效显著且安全。

Objective To observe the clinical therapeutic effect and safety of Maixuekang capsule on old patients with convalescing cerebral infarction. Methods 180 patients aged 60 years or older convalescent patients with cerebral infarction were randomly divided into study group （n=90） and control group （n=90）. Both groups were given oral compound Danshen tablets, nimodipine tablets, aspirin enteric-coated tablets, piracetam tablets and other conventional treatment, and control of blood glucose, blood lipids, blood pressure. The study group on that basis was given oral Maixuekang capsule （4 pills tid）.The study course was 6 weeks for both group. Results In study group, the total effective rate was 92.22%, while in control group that was 77.78%.The study group was better than the control group. The difference was statistically significant （P 〈 0.05）. Blood rheology indexes were significantly improved in the study group （P 〈 0.05）, while those indicators were not significantly improved in the control group （P 〉 0.05）. Both groups had no apparent adverse reaction. Conclusion Maixuekang capsule in the treatment of senile cerebral infarction in convalescence is very effective and safe.